Editor’s note: Part 2 of 3.

KPMG’s study, “Medical devices 2030: Making a power play to avoid the commodity trap,” predicts that throughout the next 12 years, the cardiovascular care journey will be fundamentally altered with the introduction of numerous innovations. Treatment protocols will significantly evolve, enabled by advances in technologies such as 3D printing and augmented/virtual reality, and the launches of several smart devices. The September issue looked at the future of ophthalmic care. Next issue, we look at orthopedics.

5 years:
  • 3D-printed surgical planning models/instruments
  • Artificial intelligence diagnosis
10 years:
  • Thread-based diagnostics devices
  • Biostamps
15 years:
  • Intelligent balloon catheters

Manufacturers are integrating intelligence into their devices, offering real-time insights based on patient data. AliveCor has developed a medical-grade electrocardiogram (ECG/EKG) band, which can be used by smartwatch wearers to detect cardiac arrhythmia conditions causing stroke and measure heart rate and rhythm. The band works with a smart app that processes the data from device sensors, allowing its wearers to record voice memos to be sent along with the ECG/EKG to their doctor. ~ KPMG

Download KPMG’s 2030 report at https://tinyurl.com/yc42jolp.